Gene · 4928
Papers2,783
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 2,783
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML): Moving beyond Prognostication. | Int J Mol Sci | 2023 | 36902217 | PubTator, text mining | PubMed |
| Tuning between Nuclear Organization and Functionality in Health and Disease. | Cells | 2023 | 36899842 | PubTator, text mining | PubMed |
| Non-Synonymous Variants in Fat QTL Genes among High- and Low-Milk-Yielding Indigenous Breeds. | Animals (Basel) | 2023 | 36899741 | PubTator, text mining | PubMed |
| Dual IKZF2 and CK1α degrader targets acute myeloid leukemia cells. | Cancer Cell | 2023 | 36898380 | PubTator, text mining | PubMed |
| A general highly efficient synthesis of biocompatible rhodamine dyes and probes for live-cell multicolor nanoscopy. | Nat Commun | 2023 | 36894547 | PubTator, text mining | PubMed |
| Nasal administration of anti-CD3 mAb (Foralumab) downregulates NKG7 and increases TGFB1 and GIMAP7 expression in T cells in subjects with COVID-19. | Proc Natl Acad Sci U S A | 2023 | 36881624 | PubTator, text mining | PubMed |
| Characterization of bone marrow heterogeneity in NK-AML (M4/M5) based on single-cell RNA sequencing. | Exp Hematol Oncol | 2023 | 36879313 | PubTator, text mining | PubMed |
| Biomolecular condensates: Formation mechanisms, biological functions, and therapeutic targets. | MedComm (2020) | 2023 | 36875159 | PubTator, text mining | PubMed |
| Unmanipulated haploidentical hematopoietic stem cell transplantation for pediatric de novo acute megakaryoblastic leukemia without Down syndrome in China: A single-center study. | Front Oncol | 2023 | 36874138 | PubTator, text mining | PubMed |
| Feasibility of high-throughput drug sensitivity screening (HDS)-guided treatment for children with refractory or relapsed acute myeloid leukemia. | Front Pediatr | 2023 | 36873635 | PubTator, text mining | PubMed |
| Widespread allele-specific topological domains in the human genome are not confined to imprinted gene clusters. | Genome Biol | 2023 | 36869353 | PubTator, text mining | PubMed |
Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia. | Am J Hematol | 2023 | 36861732 | PubTator, text mining | PubMed |
| Relapsed pediatric acute myeloid leukaemia: state-of-the-art in 2023. | Haematologica | 2023 | 36861399 | PubTator, text mining | PubMed |
| The Dynamic Linkage between Provirus Integration Sites and the Host Functional Genome Property Alongside HIV-1 Infections Associated with Antiretroviral Therapy. | Vaccines (Basel) | 2023 | 36851277 | PubTator, text mining | PubMed |
| Case report: Compound heterozygous NUP85 variants cause autosomal recessive primary microcephaly. | Front Neurol | 2023 | 36846113 | PubTator, text mining | PubMed |
| Overexpressed Nup88 stabilized through interaction with Nup62 promotes NF-κB dependent pathways in cancer. | Front Oncol | 2023 | 36845732 | PubTator, text mining | PubMed |
| Germline NUP98 Variants in Two Siblings with a Rothmund-Thomson-Like Spectrum: Protein Functional Changes Predicted by Molecular Modeling. | Int J Mol Sci | 2023 | 36835439 | PubTator, text mining | PubMed |
| Phase Separation: Direct and Indirect Driving Force for High-Order Chromatin Organization. | Genes (Basel) | 2023 | 36833426 | PubTator, text mining | PubMed |
| The Role of CREBBP/EP300 and Its Therapeutic Implications in Hematological Malignancies. | Cancers (Basel) | 2023 | 36831561 | PubTator, text mining | PubMed |
| Global profiling of AMG510 modified proteins identified tumor suppressor KEAP1 as an off-target. | iScience | 2023 | 36824285 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4928/papers?page=23